When standard antidepressants fail, treatment-resistant depression (TRD) requires specialized approaches. Learn about FDA-approved augmentation strategies, advanced therapies like rTMS and esketamine, and what to expect from each option. Real-world data on effectiveness and side effects.
Feb, 4 2026
